0001493152-25-014792.txt : 20250924 0001493152-25-014792.hdr.sgml : 20250924 20250924160013 ACCESSION NUMBER: 0001493152-25-014792 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250916 FILED AS OF DATE: 20250924 DATE AS OF CHANGE: 20250924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dearen Danny L. CENTRAL INDEX KEY: 0001756438 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35731 FILM NUMBER: 251338128 MAIL ADDRESS: STREET 1: 26 TECHNOLOGY DRIVE CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InspireMD, Inc. CENTRAL INDEX KEY: 0001433607 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 262123838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6303 WATERFORD DISTRICT DRIVE STREET 2: SUITE 215 CITY: MIAMI STATE: FL ZIP: 33126 BUSINESS PHONE: (888) 776-6804 MAIL ADDRESS: STREET 1: 6303 WATERFORD DISTRICT DRIVE STREET 2: SUITE 215 CITY: MIAMI STATE: FL ZIP: 33126 FORMER COMPANY: FORMER CONFORMED NAME: Saguaro Resources, Inc. DATE OF NAME CHANGE: 20080428 3 1 ownership.xml X0206 3 2025-09-16 0 0001433607 InspireMD, Inc. NSPR 0001756438 Dearen Danny L. C/O INSPIREMD, INC. 6303 WATERFORD DISTRICT DRIVE, SUITE 215 MIAMI FL 33126 1 0 0 0 Common Stock 58017 D Options to purchase common stock (right to buy) 2.41 2035-09-16 Common Stock 28206 D These shares of common stock represent (1) 2,000 shares of common stock purchased by the Reporting Person on the open market and (2) 56,017 shares of restricted stock, which vest on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested shares of restricted stock will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable). The options vest and become exercisable on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested options will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable). /s/ Danny L. Dearen 2025-09-23